Bacterial Infections  >>  PREVNAR 13 (pneumococcal 13-valent conjugate vaccine)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
NCT01531322 / 2014-004180-20: A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

Completed
1
72
RoW
13-valent Pneumococcal Conjugate Vaccine
Pfizer
Pneumococcal Infection
01/12
01/12
NCT02558751: Pneumonia Vaccine in Aging HIV Positive Individuals

Completed
1
51
US
23-valent pneumococcal polysaccharide vaccine, PPV23 or Pneumovax, 13-valent pneumococcal conjugate vaccine, PCV13 or Prevnar 13
University of Toledo Health Science Campus, National Institute on Aging (NIA)
Pneumococcal Infection
06/15
06/15

Download Options